Investigation of whether varying levels of population stratification adjustment altered PRS portability in three broad ancestry groups in the UK Biobank found that increasing PC adjustment did not produce a consistent trend in portability across ancestry groups or phenotypes, despite modest reductions in the LDSC intercept.
Abstract
Polygenic risk scores (PRS) offer considerable potential for precision medicine. How ever, their predictive performance often attenuates when applied to populations that differ from the genome-wide association study (GWAS) training population. There are many potential sources of this portability problem, and one relatively under-explored contributor is the presence of residual confounding in GWAS summary statistics. In particular, confounding specific to the training population may contribute to predictive performance that does not transfer to other populations, such that improved control of population stratification could potentially improve PRS portability. Here, we investigated whether varying levels of population stratification adjustment, through the inclusion of principal components and the use of mixed models, altered PRS portability in three broad ancestry groups in the UK Biobank. The PRS were built using European training data for coronary artery disease and type 2 diabetes and subsequently evaluated in South Asian, African, and Latin American participants. We found that increasing PC adjustment did not produce a consistent trend in portability across ancestry groups or phenotypes, despite modest reductions in the LDSC intercept. However, substantial ancestry- and phenotype-specific effects on transferability were observed. Mixed-model association provided no significant change in PRS discrimination or portability. These findings highlight the need for a better understanding of the nature of residual confounding in PRS and whether improving the causal validity of GWAS results can ultimately improve the transferability of predictive accuracy between populations.
This review outlines four major PRS-informed design strategies: tail sampling based on PRS extremes; discordance sampling based on mismatch between phenotype and PRS-implied risk; conditional and stratified genome-wide association analyses using PRS to adjust for / partition background risk; and residual phenotype anal...
Hui-Qi Qu, H. Hakonarson· Human Genetics· 0 citations
Leveraging multiancestry and multi-biobank data from the All of Us Research Program and the UK Biobank improves polygenic prediction models for complex traits and diseases, especially for under-represented populations.
K. Tsuo, Zhuo-Zheng Shi, Tian Ge et al.· Nature Genetics· 0 citations
Type 2 diabetes (T2D) is a highly heterogeneous metabolic trait, with a higher prevalence in East Asians. Despite extensive genetic studies focusing mainly on Europeans, how genetic risk for T2D is distributed across biological pathways in East Asians in comparison with Europeans remains incompletely understood. Here,...
This review summarizes the principles of PRS, the main sources of variability between models, and its potential applications in risk stratification and personalized cancer screening and addresses limitations in transferability, the need for calibration, and the currently limited evidence for improvements in hard clinic...
Adéla Mišove, E. Macháčková, Klára Nováková et al.· Klinicka onkologie· 0 citations
Functional annotation-informed PRSs and expanded reference panels modestly improved prediction, particularly among EA participants, and limited performance among AA participants underscores the need for larger, more diverse genomic datasets and integrative models incorporating genetic, clinical, lifestyle, and social d...
N. Armstrong, V. Srinivasasainagendra, Amit Patki et al.· Frontiers in Bioinformatics· 0 citations
Investigating the utility of genome-wide association study - derived PRS and pathway-specific PRS in the Latvian population and demonstrating superior discrimination compared to pathway-specific PRS found incorporation of PRS enhances early-onset CAD risk prediction.
E. Kanašniece, Elita Ozola, L. Bardina et al.· American Heart Journal Plus:...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.